As of 2025-05-07, the EV/EBITDA ratio of Fisher & Paykel Healthcare Corporation Ltd (FPH.NZ) is 49.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FPH.NZ's latest enterprise value is 20,905.16 mil NZD. FPH.NZ's TTM EBITDA according to its financial statements is 418.90 mil NZD. Dividing these 2 quantities gives us the above FPH.NZ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 17.7x | 16.5x |
| Forward P/E multiples | 8.9x - 11.8x | 9.6x |
| Fair Price | 8.54 - 12.59 | 10.47 |
| Upside | -76.0% - -64.6% | -70.6% |
| Date | EV/EBITDA |
| 2025-05-05 | 49.90 |
| 2025-05-02 | 49.40 |
| 2025-05-01 | 48.83 |
| 2025-04-30 | 47.67 |
| 2025-04-29 | 48.09 |
| 2025-04-28 | 48.53 |
| 2025-04-24 | 47.04 |
| 2025-04-23 | 46.83 |
| 2025-04-22 | 45.57 |
| 2025-04-17 | 46.97 |
| 2025-04-16 | 47.13 |
| 2025-04-15 | 46.76 |
| 2025-04-14 | 47.11 |
| 2025-04-11 | 46.83 |
| 2025-04-10 | 48.31 |
| 2025-04-09 | 46.27 |
| 2025-04-08 | 47.04 |
| 2025-04-07 | 46.90 |
| 2025-04-04 | 48.48 |
| 2025-04-03 | 49.35 |
| 2025-04-02 | 49.21 |
| 2025-04-01 | 48.37 |
| 2025-03-31 | 47.02 |
| 2025-03-28 | 47.18 |
| 2025-03-27 | 47.90 |
| 2025-03-26 | 48.51 |
| 2025-03-25 | 46.35 |
| 2025-03-24 | 45.71 |
| 2025-03-21 | 45.64 |
| 2025-03-20 | 45.78 |
| 2025-03-19 | 45.57 |
| 2025-03-18 | 45.08 |
| 2025-03-17 | 45.99 |
| 2025-03-14 | 46.13 |
| 2025-03-13 | 46.20 |
| 2025-03-12 | 46.71 |
| 2025-03-11 | 49.00 |
| 2025-03-10 | 49.11 |
| 2025-03-07 | 48.37 |
| 2025-03-06 | 48.09 |
| 2025-03-05 | 48.62 |
| 2025-03-04 | 46.97 |
| 2025-03-03 | 47.54 |
| 2025-02-28 | 47.78 |
| 2025-02-27 | 48.51 |
| 2025-02-26 | 48.53 |
| 2025-02-25 | 48.37 |
| 2025-02-24 | 48.44 |
| 2025-02-21 | 49.21 |
| 2025-02-20 | 49.14 |